Sai Life Sciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and WHO-GMP.
They are recognized for Delivering Contract Development & Manufacturing Solutions, through a broad suite of expert capabilities across the molecular lifecycle
One of their notable products is DOXERCALCIFEROL USP, with a corresponding US DMF Number 22120.
Remarkably, this DMF maintains an Active status since its submission on October 27, 2008, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 25, 2014, and payment made on March 10, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II